SCHEMBL10183659

SCHEMBL10183659

C=C(CNC1CCC1)N(c1cccc(F)c1)C1C(=O)N(C2CCCCC2)c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 2/20 0.36
▸ OPRK1 P41145 2/20 0.36
▸ OPRL1 P41146 2/20 0.36
▸ IDH1 O75874 7/20 0.34
▸ LMNA P02545 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ CCKAR P32238 2/20 0.33
▸ CCKBR P32239 2/20 0.33
▸ AGTR2 P50052 1/20 0.33
▸ NPC1 O15118 2/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ CYP1A2 P05177 2/20 0.32
▸ CYP2D6 P10635 2/20 0.32
▸ CYP2C9 P11712 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ EPHX2 P34913 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ XBP1 P17861 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183654 0.90 IDH1 (0.38) OPRM1OPRK1OPRL1IDH1LMNA
SCHEMBL10184071 0.82 OPRM1 (0.37) OPRM1OPRK1OPRL1IDH1LMNA
SCHEMBL10183782 0.81 OPRM1 (0.40) OPRM1OPRK1OPRL1IDH1LMNA
SCHEMBL10183299 0.81 OPRM1 (0.40) OPRM1OPRK1OPRL1IDH1LMNA
SCHEMBL10183319 0.80 MEN1 (0.43) OPRM1OPRK1OPRL1IDH1LMNA
SCHEMBL10183337 0.80 OPRM1 (0.39) OPRM1OPRK1OPRL1IDH1LMNA
SCHEMBL10183669 0.79 CCKBR (0.41) OPRM1OPRK1OPRL1IDH1LMNA
SCHEMBL10184119 0.79 OPRM1 (0.37) OPRM1OPRK1OPRL1IDH1LMNA
SCHEMBL10185886 0.79 IDH1 (0.46) OPRM1OPRK1OPRL1IDH1TP53
SCHEMBL10183927 0.79 OPRM1 (0.36) OPRM1OPRK1OPRL1IDH1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback